Nisha Pandey

Three Deaths In Chinese Gene Therapy Trials Raise Safety Concerns: Experimental Treatments Under Scrutiny

The deaths of three patients in experimental gene-editing and cell-therapy trials in <span>China</span>, including two children, have raised grave concerns about patient safety, transparency and oversight in the country's clinical-trial system.

The three deaths occurred in separate investigator-initiated trials (IITs), which are studies led by researchers or medical institutions rather than conducted through the conventional drug-development pathway. 

The cases have come to light only months after the deaths, prompting US lawmakers to ask the <span>FDA</span> to scrutinise clinical data generated in China more closely. 

<h2>Three Patients Died In Separate Experimental Trials</h2>

One case involved a 6-year-old girl with <a href="https://www.healthandme.com/nutrition/neurogenesis-is-possible-add-these-food-items-to-your-diet-to-regrow-brain-cells-article-151211269" data-type="tilCustomLink">Snijders Blok-Campeau syndrome</a>, a rare neurodevelopmental disorder. She died seven days after receiving an experimental gene-editing treatment at <span>Xinhua Hospital</span> in Shanghai in May 2025. 

Reports said the treatment was delivered into the spinal fluid, and the hospital's ethics board later determined that the death was definitely related to the treatment. 

A second death involved a boy with Duchenne muscular dystrophy (DMD) who received HuidaGene Therapeutics' experimental CRISPR-based therapy. He died in August 2025 after developing acute respiratory distress syndrome (ARDS) during a severe immune reaction following a high dose of the viral-vector treatment. The company disclosed the death in August 2026 after questions from reporters. 

The third case involved a man in his 50s with scleroderma, who died in March 2026 after receiving RiboX Therapeutics' experimental in-vivo CAR-T therapy. 

RiboX had announced <a href="https://www.healthandme.com/health-news/man-with-diabetes-produces-own-insulin-after-worlds-first-gene-edited-cell-transplant-article-152488757" data-type="tilCustomLink">FDA</a> clearance to begin testing the treatment in the US shortly before the death became public.

Also read: <a href="https://www.healthandme.com/health-news/early-trial-examines-a-one-time-treatment-that-could-replace-statins-to-manage-high-cholesterol-study-article-155692978" data-type="tilCustomLink">Early Trial Examines A One-Time Treatment That Could Replace Statins To Manage High Cholesterol: Study</a>

<h2>Why <span rel="noindex">Gene Therapy</span> Can Trigger Serious Reactions?</h2>

<a href="https://www.healthandme.com/health-news/surgeons-transplant-first-ever-gene-edited-pig-lung-into-a-brain-dead-man-article-152524552" data-type="tilCustomLink">Gene therapies</a> often use delivery systems such as adeno-associated viruses (AAVs) or other vectors to transport genetic material into cells. The immune system can recognise these vectors as foreign. In some circumstances, this can trigger an intense inflammatory or immune response.

High doses can further increase this risk. In the HuidaGene case, the child developed ARDS during what the company described as a severe immune reaction. Such reactions can cause widespread inflammation and damage organs, making them potentially life-threatening. 

Gene editing also carries another category of risk: the treatment is intended to alter genetic material, so researchers must carefully assess whether editing occurs only at the intended target and whether the delivery system itself creates additional risks.

Also read: <a href="https://www.healthandme.com/health-news/uk-plans-22-million-mini-human-organs-project-to-cut-down-animal-testing-in-science-article-155607127" data-type="tilCustomLink">UK Plans £22 Million Mini Human Organs Project To Cut Down Animal Testing In Science</a>

<h2>Bigger Concern Is Trial Oversight</h2>

H1N1 Cases Surge in Delhi: Doctor Explains Symptoms, Warning Signs, Vaccine & Treatment

The deaths have attracted particular attention because they occurred in trials initiated by investigator, which have historically offered researchers a faster route to testing experimental therapies.

Unlike conventional clinical trials, these studies have operated under a different regulatory framework in China. Reports have raised concerns about whether independent safety monitoring was adequate in some cases.

For example, the <a href="https://www.healthandme.com/health-news/after-pig-kidney-transplants-scientists-may-have-found-a-way-to-transplant-pig-livers-article-151304856" data-type="tilCustomLink">HuidaGene trial</a> did not have an independent data safety monitoring board, according to reporting by STAT. The study enrolled four boys, and the child who died was the fourth participant to receive treatment and received the highest dose administered in the trial. 

<h2>US Lawmakers Are Calling For Greater Scrutiny</h2>

The cases have prompted Representatives John Moolenaar and Ben Cline to ask the FDA to stop accepting <a href="https://www.healthandme.com/health-wellness/flesh-eating-screwworm-parasite-detected-in-first-us-human-case-know-the-warning-signs-of-new-world-screwworm-article-152525762" data-type="tilCustomLink">Chinese clinical-trial data</a> for US drug applications unless the agency has recently inspected the trial site.

In a letter to Acting FDA Commissioner Kyle Diamantas, the lawmakers said, “American families deserve confidence that the treatments approved in our country are supported by data produced with rigor, ethics, and accountability.”

Health Conditions A-Z

health

three-deaths-in-chinese-gene-therapy-trials-raise-safety-concerns-experimental-treatments-under-scrutiny

Gene Therapy

Chinese Gene Therapy trial

china

xinhua hospital

Chinese Gene Therapy deaths

tivicay-us-fda-approves-drug-to-treat-hiv-in-newborns

Tivicay: US FDA Approves Drug to Treat HIV In Newborns

1-in-4-former-nfl-players-had-cte-at-death-effects-of-repeated-head-trauma-does-to-the-brain

1 In 4 Former NFL Players Had CTE At Death: Effects Of Repeated Head Trauma Does On The Brain

Health News

8 Sit-Up Variations to Strengthen Your Core and Build Stability

Benefits Of Ayurvedic Health Supplement Ashwagandha

9 Anti-Inflammatory Breakfast Options You Should Try

5 Foods You Should Avoid For PCOS, Says Gynecologist

Love Sitting With Your Legs Crossed? Here’s You Should Avoid It

6 Daily Foods That Are Secretly Increasing Your Calories

9 Brain Boosters You Should Do Everyday

Hip Exercises That Will Keep You Flexible As You Age

9 Leg Exercises Office Workers’ Should Do At Home

Benefits of Having Herbal Tea Every Morning

9 Daily Habits That Boost Your Brain Power

Lower-Body Exercises That Are Game-Changers

How Drinking Apple Cider Vinegar Helps You

Aging Myths You Should Never Believe

Superfoods That Support Your Gut Health

What Happens To Your Body When You Eat Instant Noodles Every Day?

Health Issues Premature Babies Often Face

Exercises Office Workers Should Do For Their Heart Health

Reasons Why You Should Add Raw Turmeric To Your Diet

Benefits Of Drinking Milk At Night: Why You Should Do It

Food That Provides Vitamin B12 Naturally In Your Diet

Surprising Health Benefits Of Fenugreek Seeds

9 Superfoods You Should Eat For Your Brain Health

What Does Mental Health Support Look Like At Work?

Long Stretches You Should Do To Unwind From Your Day

Colon Cancer In Young Adults: Early Symptoms You Should Know

Health Benefits Of Eating Dry Fruits Everyday

Are You At Risk For Fried Rice Syndrome?

These Tests Reveal How Well You Are Aging

Lower-Back Exercises You Should Do After A Long-Day's Work

Children’s Diet – What Kids Need To Eat For Immunity Building

Common Diabetes Myths That Could Hurt Your Health

Love Spicy Food? Here’s How It Affects Your Health

Superfood List: Veggies And Fruits You Must Have For Immunity

Foods People With IBS Should Avoid

Exercises To Improve Digestion

Easy Work Lunches You Can Make In The Morning

Hunger Vs Craving: Difference Explained In 60 seconds

These Things Can Cause Your Heart To Age Faster

High Carb Foods That Are Actually Healthy

The deaths of three patients in experimental gene-editing and cell-therapy trials in China, including two children, have raised grave concerns about patient safety, transparency and oversight in the country's clinical-trial system.The three deaths occurred in separate investigator-initiated trials (IITs), which are studies led by researchers or medical institutions rather than conducted through the conventional drug-development pathway. The cases have come to light only months after the deaths, prompting US lawmakers to ask the FDA to scrutinise clinical data generated in China more closely. Three Patients Died In Separate Experimental TrialsOne case involved a 6-year-old girl with Snijders Blok-Campeau syndrome, a rare neurodevelopmental disorder. She died seven days after receiving an experimental gene-editing treatment at Xinhua Hospital in Shanghai in May 2025. Reports said the treatment was delivered into the spinal fluid, and the hospital's ethics board later determined that the death was definitely related to the treatment. A second death involved a boy with Duchenne muscular dystrophy (DMD) who received HuidaGene Therapeutics' experimental CRISPR-based therapy. He died in August 2025 after developing acute respiratory distress syndrome (ARDS) during a severe immune reaction following a high dose of the viral-vector treatment. The company disclosed the death in August 2026 after questions from reporters. The third case involved a man in his 50s with scleroderma, who died in March 2026 after receiving RiboX Therapeutics' experimental in-vivo CAR-T therapy. RiboX had announced FDA clearance to begin testing the treatment in the US shortly before the death became public.Also read: Early Trial Examines A One-Time Treatment That Could Replace Statins To Manage High Cholesterol: StudyWhy Gene Therapy Can Trigger Serious Reactions?Gene therapies often use delivery systems such as adeno-associated viruses (AAVs) or other vectors to transport genetic material into cells. The immune system can recognise these vectors as foreign. In some circumstances, this can trigger an intense inflammatory or immune response.High doses can further increase this risk. In the HuidaGene case, the child developed ARDS during what the company described as a severe immune reaction. Such reactions can cause widespread inflammation and damage organs, making them potentially life-threatening. Gene editing also carries another category of risk: the treatment is intended to alter genetic material, so researchers must carefully assess whether editing occurs only at the intended target and whether the delivery system itself creates additional risks.Also read: UK Plans £22 Million Mini Human Organs Project To Cut Down Animal Testing In ScienceBigger Concern Is Trial Oversight      The deaths have attracted particular attention because they occurred in trials initiated by investigator, which have historically offered researchers a faster route to testing experimental therapies.Unlike conventional clinical trials, these studies have operated under a different regulatory framework in China. Reports have raised concerns about whether independent safety monitoring was adequate in some cases.For example, the HuidaGene trial did not have an independent data safety monitoring board, according to reporting by STAT. The study enrolled four boys, and the child who died was the fourth participant to receive treatment and received the highest dose administered in the trial. US Lawmakers Are Calling For Greater ScrutinyThe cases have prompted Representatives John Moolenaar and Ben Cline to ask the FDA to stop accepting Chinese clinical-trial data for US drug applications unless the agency has recently inspected the trial site.In a letter to Acting FDA Commissioner Kyle Diamantas, the lawmakers said, “American families deserve confidence that the treatments approved in our country are supported by data produced with rigor, ethics, and accountability.”

three deaths in chinese gene therapy trials raise safety concerns: experimental treatments under scrutiny

About Us

Contact Us

Terms & Conditions

Privacy Policy

Company

Health and Me is a premium website with content written and curated to function as a handbook for all Health concerns.

Three Deaths In Chinese Gene Therapy Trials Raise Safety Concerns: Experimental Treatments Under Scrutiny

Tivicay: US FDA Approves Drug to Treat HIV In Newborns

1 In 4 Former NFL Players Had CTE At Death: Effects Of Repeated Head Trauma Does On The Brain

Dolly Parton Dies At 80 After ‘Brief Battle With Cancer’: What We Know So Far?

Health Conditions A-Z

Tivicay: US FDA Approves Drug to Treat HIV In Newborns

Three Deaths In Chinese Gene Therapy Trials Raise Safety Concerns: Experimental Treatments Under Scrutiny

1 In 4 Former NFL Players Had CTE At Death: Effects Of Repeated Head Trauma Does On The Brain